全球风疹治疗市场，按治疗（药物和疫苗接种）、药物（对乙酰氨基酚、布洛芬、阿司匹林等）、疫苗（Proquad、MMR II 等）、给药途径（口服和注射）、最终用户（医院、家庭护理、专科诊所、其他）、分销渠道（医院药房、网上药房、零售药房）划分 - 行业趋势和预测到 2029 年。
风疹治疗市场分析和规模
预计全球风疹治疗市场将在预测期内出现显着增长。风疹发病率的增加是披膜病毒通过空气的高传播能力的直接后果。风疹感染通常影响儿童和成人。该疾病对孕妇有严重影响，导致胎儿死亡或先天性缺陷。根据世界卫生组织的记录，194 个国家中有 168 个国家在其健康计划中引入了风疹疫苗，截至 2018 年 12 月，全球覆盖率约为 69%。COVID-19 也对市场增长产生了重大影响。
Data Bridge Market Research 分析了 2022-2029 年预测期内风疹治疗市场的增长率。在上述预测期内，风疹治疗市场的预期复合年增长率往往约为 6.50%。除了市场价值、增长率、细分市场、地理覆盖范围、市场参与者和市场情景等市场洞察外，Data Bridge Market Research 团队策划的市场报告还包括深入的专家分析、患者流行病学、渠道分析、定价分析和监管框架。
风疹治疗市场范围和细分
|
报告指标 |
细节 |
|
预测期 |
2022 至 2029 年 |
|
基准年 |
2021 |
|
历史岁月 |
2020（可定制为 2014 - 2019） |
|
定量单位 |
收入（百万美元）、销量（单位）、定价（美元） |
|
涵盖的领域 |
治疗（药物和疫苗接种）、药品（扑热息痛、布洛芬、阿司匹林等）、疫苗（Proquad、MMR II 等）、给药途径（口服和注射）、最终用户（医院、家庭护理、专科诊所等）、分销渠道（医院药房、网上药房、零售药房） |
|
覆盖国家 |
北美洲的美国、加拿大和墨西哥、德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、巴西、阿根廷和南美洲其他地区 |
|
涵盖的市场参与者 |
Merck KGaA (Germany), Novartis AG (U.S.), Mylan N.V. (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Sanofi (France), Novartis AG (Switzerland), Sun Pharmaceutical Industries Ltd. (India), Aurobindo Pharma (India), GSK plc (U.K.), F. Hoffmann-La Roche Ltd. (Switzerland), AstraZeneca (U.K.), Lilly (U.S.) |
|
Market Opportunities |
|
Market Definition
Rubella is also known as German measles and is a contagious viral infection caused by rubivirus infection. Rubella is typically characterized by rash, fever and eye redness and is usually found in children. It spreads through air or in contact with the infected person. Rubella infection commonly affects children and adults. The infection has severe implications in pregnant women, that can lead to fetal death or congenital defects.
Global Rubella Treatment Market Dynamics
Drivers
- Increased Demand of Diagnostic Tests
Diagnostic tests such as flow cytometry, monoclonal antibodies, immunoassays, latex slide agglutination test, serological testing, and clinical evaluation are boosting the growth of the market. These tests are characteristically prescribed for pregnant women and also for women planning to conceive. These tests may also be conducted for babies having congenital defects. Thus, it boosts the market growth.
- Growing Government Initiatives
Numerous government initiatives relating to research and development of advanced diagnostic techniques in developing countries such as China and India are performed, which is anticipated to boost the market growth in the near future. This boost the growth of the market.
Opportunities
- Rising Demand of MMR Vaccines
Growing demand for measles, mumps and rubella (MMR) vaccines for the protection of children against rubella and the launch of advanced point-of-care diagnostic technologies such as BioPlex 2200 MMRV (varicella zoster, rubella, mumps and measles virus) by Bio Rad Laboratories are moreover creating growth opportunities for the global rubella market.
- Increasing Demand for Retail Pharmacies
The rise in the number of perinatal infections therapeutics delivered through retail pharmacies and more retail pharmacies in developed countries create opportunities for the market expansion. Additionally, patients choose retail pharmacies over other types for purchasing drugs, as these are easily accessible.
Restraints/Challenges
- Lack of skilled professionals
The lack of appropriate healthcare professionals who cannot treat the patients with suitable treatments could curb the growth of the global rubella treatment market over a forecast period.
- Unavailability of Vaccinations
疫苗普遍短缺，阻碍了市场增长。这些地区无法接种风疹疫苗。据记录，截至 2013 年，泰国、东帝汶、马其顿、塔吉克斯坦和叙利亚的风疹感染病例最多，但疫苗和药物短缺阻碍了市场增长。
这份全球风疹治疗市场报告详细介绍了最新发展、贸易法规、进出口分析、生产分析、价值链优化、市场份额、国内和本地市场参与者的影响，分析了新兴收入来源、市场法规变化、战略市场增长分析、市场规模、类别市场增长、应用领域和主导地位、产品批准、产品发布、地域扩展、市场技术创新等方面的机会。如需了解有关全球风疹治疗市场的更多信息，请联系 Data Bridge Market Research 获取分析师简报，我们的团队将帮助您做出明智的市场决策，实现市场增长。
全球风疹治疗市场范围
全球风疹治疗市场根据药物、疫苗、治疗、给药途径、分销渠道和最终用户进行细分。这些细分市场之间的增长将帮助您分析行业中增长微弱的细分市场，并为用户提供有价值的市场概览和市场洞察，帮助他们做出战略决策，确定核心市场应用。
药物
- 扑热息痛
- 布洛芬
- 阿司匹林
- 其他的
治疗
- 药物
- 疫苗接种
疫苗
- 普罗夸克
- 骨髓增生异常综合征
- 其他的
给药途径
- 口服
- 注射剂
最终用户
- 医院
- 家庭护理
- 专科诊所
- 其他的
分销渠道
- 医院药房
- 网上药店
- 零售药店
风疹治疗市场区域分析/见解
对全球风疹治疗市场进行了分析，并按上述药物、疫苗、治疗、给药途径、分销渠道和最终用户提供了市场规模洞察和趋势。
全球风疹治疗市场报告涉及的主要国家 有：北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区（APAC）的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区（APAC）的其他地区、中东和非洲（MEA）的其他地区、南美洲的巴西、阿根廷和南美洲其他地区。
由于现代医疗技术的不断普及以及联邦政府采取措施提高人们的认识，在预测期内，北美的全球风疹治疗市场一直呈现积极增长态势。
由于医疗基础设施建设支出不断增加、尚未开发的机会以及个人可支配收入不断增加，亚太地区占据了市场主导地位。
报告的国家部分还提供了影响市场当前和未来趋势的各个市场影响因素和国内市场监管变化。此外，在提供国家数据预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈竞争或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。
竞争格局和全球风疹治疗市场份额分析
全球风疹治疗市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对全球风疹治疗市场的关注有关
全球风疹治疗市场的主要参与者包括：
- 默克集团（德国）
- 诺华公司（美国）
- Mylan NV（美国）
- Teva Pharmaceutical Industries Ltd.（以色列）
- 赛诺菲（法国）
- 诺华公司（瑞士）
- 太阳制药工业有限公司 (印度)
- Aurobindo Pharma（印度）
- 葛兰素史克公司 (英国)
- F. Hoffmann-La Roche Ltd.（瑞士）
- 阿斯利康（英国）
- 礼来（美国）
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
